News Home

BioCryst Pharmaceuticals Inc (BCRX) Down 3.35% in Premarket Trading

Wednesday, August 17, 2022 07:34 AM | InvestorsObserver Analysts
BioCryst Pharmaceuticals Inc (BCRX) Down 3.35% in Premarket Trading

BioCryst Pharmaceuticals Inc (BCRX) is down -3.35%% today.

Overall Score - 56
BCRX has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on BCRX!
BCRX stock closed at $14.63 and is down -$0.49 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. BCRX has a roughly average overall score of 56 meaning the stock holds a better value than 56% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. BCRX gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. BioCryst Pharmaceuticals Inc currently has the 119th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.
BioCryst Pharmaceuticals Inc's Overall and Short-Term Technical score paint a mixed picture for BCRX's recent trading patterns and forecasted price. Click Here To Get The Full Report on BioCryst Pharmaceuticals Inc (BCRX)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App